Aptose Biosciences Stock Analysis

Aptose Stock Analysis Notes

The company recorded a loss per share of 4.18. Aptose Biosciences had not issued any dividends in recent years. The entity had 1:15 split on the 6th of June 2023. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Toronto, Canada. APTOSE BIOSCIENCES operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people. For more info on Aptose Biosciences please contact William Rice at 647 479 9828 or go to https://www.aptose.com.

Aptose Biosciences Investment Alerts

Aptose Largest EPS Surprises

View All Earnings Estimates

Aptose Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aptose Biosciences's market, we take the total number of its shares issued and multiply it by Aptose Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Aptose Profitablity

Management Efficiency

Aptose Biosciences has return on total asset (ROA) of (1.3629) % which means that it has lost $1.3629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9413) %, meaning that it generated substantial loss on money invested by shareholders. Aptose Biosciences' management efficiency ratios could be used to measure how well Aptose Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aptose Biosciences' Return On Capital Employed is very stable compared to the past year. As of the 23rd of January 2025, Return On Equity is likely to grow to 16.68, though Return On Tangible Assets are likely to grow to (4.31). At this time, Aptose Biosciences' Total Assets are very stable compared to the past year. As of the 23rd of January 2025, Non Current Assets Total is likely to grow to about 1.7 M, though Non Currrent Assets Other are likely to grow to (41.04).

Technical Drivers

As of the 23rd of January, Aptose Biosciences shows the Mean Deviation of 5.38, standard deviation of 11.2, and Risk Adjusted Performance of (0.02). Aptose Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aptose Biosciences Price Movement Analysis

Aptose Biosciences Outstanding Bonds

Aptose Biosciences Predictive Daily Indicators

Aptose Biosciences Forecast Models

Aptose Biosciences' time-series forecasting models are one of many Aptose Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aptose Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aptose Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aptose shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aptose Biosciences. By using and applying Aptose Stock analysis, traders can create a robust methodology for identifying Aptose entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.